tert-butyl 7-(4-(ethoxycarbonyl)-4-methylpiperidin-1-yl)-5-oxa-2,6-diazaspiro[3.4]oct-6-ene-2-carboxylate 、 6-cyclopropyl-4-ethoxy-5-(4-fluorophenyl)pyridine-2-carbaldehyde 以the title compound was obtained in the similar manner as in Step G of Example 1的产率得到ethyl 1-(2-((6-cyclopropyl-4-ethoxy-5-(4-fluorophenyl)pyridin-2-yl)methyl)-5-oxa-2,6-diazaspiro[3.4]oct-6-en-7-yl)-4-methylpiperidine-4-carboxylate
6-cyclopropyl-4-ethoxy-5-hydroxypyridine-2-carbaldehyde 、 4-氟苯硼酸 以the title compound was obtained in the similar manner as in Step J of Example 210的产率得到6-cyclopropyl-4-ethoxy-5-(4-fluorophenyl)pyridine-2-carbaldehyde
[EN] SPIRO AZETIDINE ISOXAZOLE DERIVATIVES AND THEIR USE AS SSTR5 ANTAGONISTS<br/>[FR] DÉRIVÉS DE SPIRO AZÉTIDINE ISOXAZOLE ET LEUR UTILISATION EN TANT QU'ANTAGONISTES DE SSTR5
申请人:TAKEDA PHARMACEUTICAL
公开号:WO2014142363A1
公开(公告)日:2014-09-18
Provided is a compound represented by the following formula (1) or a salt thereof, which has an SSTR5 antagonistic action: wherein each symbol has the same definition as in the specification.